Litcius/Paper detail

Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children

Jennifer Loske, Jobst Röhmel, Soeren Lukassen, Sebastian Stricker, Vladimir Gonçalves Magalhães, Johannes Liebig, Robert Lorenz Chua, Loreen Thürmann, Marey Messingschlager, Anke Seegebarth, Bernd Timmermann, Sven Klages, Markus Ralser, Birgit Sawitzki, Leif Erik Sander, Victor M. Corman, Christian Conrad, Sven Laudi, Marco Binder, Saskia Trump, Roland Eils, Marcus Mall, Irina Lehmann

2021Nature Biotechnology390 citationsDOIOpen Access PDF

Topics & Concepts

Innate immune systemImmunityVirologyImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyMedicineCoronavirus disease 2019 (COVID-19)Immune systemInfectious disease (medical specialty)PathologyDiseaseRespiratory viral infections researchKawasaki Disease and Coronary ComplicationsCOVID-19 Clinical Research Studies
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children | Litcius